Dr. Mascarenhas on the Benefit of Fedratinib in Myelofibrosis

Press/Media

Period	9 Mar 2023

Media coverage

Title	Dr. Mascarenhas on the Benefit of Fedratinib in Myelofibrosis
Media name/outlet	OncLive
Country/Territory	United States
Date	9/03/23
URL	https://www.onclive.com/view/dr-mascarenhas-on-the-benefit-of-fedratinib-in-myelofibrosis
Persons	John Mascarenhas